vimarsana.com
Home
Live Updates
Clinical Program In Primary Sclerosing Cholangitis - Breaking News
Pages:
Clinical Program In Primary Sclerosing Cholangitis News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Chemomab Therapeutics to Present Its CM-101 Clinical Program in Primary Sclerosing Cholangitis at 2023 Roth MKM Healthcare Opportunities Conference
Chemomab Therapeutics Ltd. , (Chemomab), a clinical stage biotechnology company developing innovative therapeutics to treat rare.
New york
United states
Barbara lindheim
Wadi mor
Clinical program in primary sclerosing cholangitis
Yale club
Strategic communications
Chemomab therapeutics ltd
Prnewswire chemomab therapeutics ltd
Present its
Primary sclerosing cholangitis
Dual anti fibrotic
Advancing towards completion
Topline readout currently targeted
Second half
Chief executive officer
vimarsana © 2020. All Rights Reserved.